News Snapshot:
Brazil’s health regulator said Monday it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an “adverse incident†involving a volunteer recipient, a blow for one of the most advanced vaccine candidates. A nurse shows a COVID-19 vaccine produced by Chinese company Sinovac Biotech at the Sao Lucas Hospital, in Porto Alegre, Brazil. (AFP / MANILA BULLETIN) The regulator, Anvisa, said in a statement it had “ruled to interrupt the clinical trial of the CoronaVac vaccine after a serious adverse incident†on October 29. It said it could not give details on what happened because of privacy regulations, but...
